SCREENING AND EARLY DETECTION OF LUNG CANCER: A COMPREHENSIVE SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/3prhn126Keywords:
Lung cancer, screening, detection, diagnosed.Abstract
Background: Lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer-related deaths globally, accounting for the greatest economic and public health burden of all cancers. In 2020, lung cancer accounted for approximately 2.2 million cases and nearly 1.8 million deaths worldwide.
The aim: The aim of this study to show about screening and early detection of lung cancer.
Methods: By the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. This search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed, SagePub, and Sciencedirect were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: Four publications were found to be directly related to our ongoing systematic examination after a rigorous three-level screening approach. Subsequently, a comprehensive analysis of the complete text was conducted, and additional scrutiny was given to these articles.
Conclusion: Early screening and diagnostic methods of lung cancer, x-ray screening is not recommended. LDCT has obvious advantages and is the most promising imaging method in early screening of lung cancer.
References
Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R, et al. Advances in lung cancer screening and early detection. Cancer Biol Med. 2022;19(5):591–608.
Gasparri R, Sabalic A, Spaggiari L. The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers. J Clin Med.2023;12(23).
Amicizia D, Piazza MF, Marchini F, Astengo M, Grammatico F, Battaglini A, et al. Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation. Healthc. 2023;11(14):1–23.
Vansteenkiste J, Dooms C, Mascaux C, Nackaerts K. Screening and early-detection of lung cancer. Ann Oncol [Internet]. 2012;23(SUPPL. 10):x320–7. Available from: https://doi.org/10.1093/annonc/mds303
Saul P. Lung cancer screening improves early detection and survival. Practitioner. 2022;166(1857):5.
Midthun DE. Early detection of lung cancer. F1000Research. 2016;5:3–12.
Ramaswamy A. Lung Cancer Screening: Review and 2021 Update. Curr Pulmonol Reports [Internet]. 2022;11(1):15–28. Available from: https://doi.org/10.1007/s13665-021-00283-1
McLellan R, Marshall H, Dent A, Bowman R V., Yang IA, Fong KM. Diagnosis and treatment of early lung cancer. Aust J Gen Pract. 2020;49(8):508–12.
Zhao SJ, Wu N. Early detection of lung cancer: Low-dose computed tomography screening in China. Thorac Cancer. 2015;6(4):385–9.
Asmara OD, Tenda ED, Singh G, Pitoyo CW, Rumende CM, Rajabto W, et al. Lung Cancer in Indonesia. J Thorac Oncol. 2023;18(9):1134–45.
Allehebi A, Al-Omair A, Mahboub B, Koegelenberg CF, Mokhtar M, Madkour AM, et al. Recommended approaches for screening and early detection of lung cancer in the Middle East and Africa (MEA) region: a consensus statement. J Thorac Dis. 2024;16(3):2142–58.
Zhao Y, Wang R, Shi F, Wu J, Jiang F, Song Q. Diagnostic Efficacy of CT Examination on Early Detection of Lung Cancer during Pandemic of COVID-19. Diagnostics. 2022;12(10):1–10.
Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest [Internet]. 2021;160(5):e427–94. Available from: https://doi.org/10.1016/j.chest.2021.06.063
Sikosek T, Horos R, Trudzinski F, Jehn J, Frank M, Rajakumar T, et al. Early Detection of Lung Cancer Using
Small RNAs. J Thorac Oncol [Internet]. 2023;18(11):1504–23. Available from: https://doi.org/10.1016/j.jtho.2023.07.005
Cainap C, Pop LA, Balacescu O, Cainap SS. Early diagnosis and screening in lung cancer. Am J Cancer Res [Internet]. 2020;10(7):1993–2009. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32774997
Kadara H, Tran LM, Liu B, Vachani A, Li S, Sinjab A, et al. Early diagnosis and screening for lung cancer. Cold Spring Harb Perspect Med. 2021;11(9):1–19.
Hassan Lemjabbar-Alaouia, Omer Hassana, Yi-Wei Yanga and PB. Lung cancer: biology and treatment options Hassan. Physiol Behav. 2017;176(5):139–48.
Xu Y, Dong X, Qin C, Wang F, Cao W, Li J, et al. Metabolic biomarkers in lung cancer screening and early diagnosis (Review). Oncol Lett. 2023;25(6):2–7.
Vicidomini G. Current Challenges and Future Advances in Lung Cancer: Genetics, Instrumental Diagnosis and Treatment. Cancers (Basel). 2023;15(14).
Tzung B, Julien PJ. Lung Cancer Screening. Med Manag Thorac Surg Patient. 2009;197–200.
Qian F, Yang W, Chen Q, Zhang X, Han B. Screening for early stage lung cancer and its correlation with lung nodule detection. J Thorac Dis. 2018;10(Suppl 7):S846–59.
Parekh A, Deokar K, Verma M, Singhal S, Bhatt ML, Katoch C. The 50-Year Journey of Lung Cancer Screening: A Narrative Review. Cureus. 2022;14(9).
Jing Ning, Tao Ge, Minilin Jiang, Keyi Jia, Lei Wang, Wei Li, et al. Jing Ning early diagnosis or lung cancer. Aging (Albany NY). 2021;13(4):6214–27.
Dama E, Colangelo T, Fina E, Cremonesi M, Kallikourdis M, Veronesi G, et al. Biomarkers and lung cancer early detection: State of the art. Cancers (Basel). 2021;13(15):1–21.
Eggert JA, Palavanzadeh M, Blanton A. Screening and Early Detection of Lung Cancer. Semin Oncol Nurs. 2017;33(2):129–40.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
